MetaStat Inc - ESG Rating & Company Profile powered by AI
The ESG score covers seventeen United Nations Sustainable Development Goals including: 'Gender Equality', 'Climate Action' and 'Life on Land'. This SDG rating for MetaStat Inc indicates its reporting of the UN Sustainable Development Goals. Other companies in the scoring peer group for MetaStat Inc are shownin the table.
MetaStat Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | MetaStat Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does MetaStat Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes MetaStat Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes MetaStat Inc report the average age of the workforce?
Sign up for free to unlockDoes MetaStat Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes MetaStat Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes MetaStat Inc disclose cybersecurity risks?
Sign up for free to unlockDoes MetaStat Inc offer flexible work?
Sign up for free to unlockDoes MetaStat Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes MetaStat Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes MetaStat Inc conduct supply chain audits?
Sign up for free to unlockDoes MetaStat Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes MetaStat Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes MetaStat Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes MetaStat Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes MetaStat Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes MetaStat Inc disclose water use targets?
Sign up for free to unlockDoes MetaStat Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid MetaStat Inc have a product recall in the last two years?
Sign up for free to unlockDoes MetaStat Inc disclose incidents of discrimination?
Sign up for free to unlockDoes MetaStat Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas MetaStat Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes MetaStat Inc disclose parental leave metrics?
Sign up for free to unlockDoes MetaStat Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes MetaStat Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes MetaStat Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes MetaStat Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes MetaStat Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes MetaStat Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs MetaStat Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes MetaStat Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes MetaStat Inc disclose its waste policy?
Sign up for free to unlockDoes MetaStat Inc report according to TCFD requirements?
Sign up for free to unlockDoes MetaStat Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes MetaStat Inc disclose energy use targets?
Sign up for free to unlockDoes MetaStat Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes MetaStat Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for MetaStat Inc
These potential risks are based on the size, segment and geographies of the company.
MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company's therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.